financetom
Business
financetom
/
Business
/
Zimmer Biomet Holdings Receives FDA Clearance for OsseoFit Stemless Shoulder System
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Zimmer Biomet Holdings Receives FDA Clearance for OsseoFit Stemless Shoulder System
Dec 13, 2024 5:39 AM

08:25 AM EST, 12/13/2024 (MT Newswires) -- Zimmer Biomet Holdings ( ZBH ) said Friday that the US Food and Drug Administration has granted 510(k) clearance for its OsseoFit Stemless Shoulder System, a new total shoulder replacement implant.

The company said the system is designed to match the natural humeral anatomy to optimize anatomical fit while preserving healthy bone.

The OsseoFit Stemless Shoulder System is expected to be commercially available in the first quarter of 2025, it added.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Copyright 2023-2026 - www.financetom.com All Rights Reserved